Osaka Organic Chemical Industry (4187) Q1 2025 earnings summary

Executive summary

• Net sales rose 20.5% year-over-year to ¥8,516 million, with growth across all business segments and operating profit up 135.2% to ¥1,365 million.

• Profit attributable to owners of parent increased 71.6% year-over-year to ¥1,035 million.

• The company launched a new medium-term management plan focused on ESG and global market expansion, especially in specialty acrylic acid esters.

• A new sales base is planned for North America to strengthen overseas sales and market development.

Financial highlights

• Net sales: ¥8,516 million, up ¥1,450 million (+20.5%) year-over-year.

• Operating profit: ¥1,365 million, up ¥785 million (+135.2%) year-over-year.

• Ordinary profit: ¥1,480 million, up ¥840 million (+131.3%) year-over-year.

• Profit attributable to owners of parent: ¥1,035 million, up ¥432 million (+71.6%) year-over-year.

• Basic earnings per share rose to ¥49.96 from ¥28.47 year-over-year.

• Comprehensive income decreased 28.3% year-over-year to ¥835 million due to negative other comprehensive income.

• Total assets decreased to ¥54,467 million from ¥59,964 million at the previous fiscal year-end, mainly due to lower cash, receivables, and investment securities.

• Net assets declined to ¥44,003 million, reflecting increased treasury shares and lower valuation on securities.

• Operating margin and gross profit margin improved, supported by decreased depreciation and favorable inventory valuation.

Outlook and guidance

• Progress rates for the first half forecast: Net sales at 50.7%, operating profit at 54.6%, ordinary profit at 57.0%, and profit attributable to owners of parent at 60.9%.

• Full-year net sales forecast at ¥34,000 million (up 4.0% year-over-year), operating profit of ¥5,000 million (up 8.5%), and profit attributable to owners of parent of ¥3,500 million (down 13.5%).

• Dividend forecast unchanged at ¥66.00 per share for FY2025.

• No change to previously announced financial results forecast.

• Forward-looking statements caution that actual results may differ due to various risks.